You are here:
Publication details
Empagliflozin and metformin synergy in proximal tubular epithelial cells: does the combination alleviates hyperglycaemia-induced metabolic stress?
Authors | |
---|---|
Year of publication | 2023 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Metformin remains the drug of first choice in type 2 diabetes mellitus (T2DM) worldwide since its beneficial metabolic effects are known for a long time. |
Related projects: |